Dr Emily He

Senior Research Fellow, Gastrointestinal Group
E: emily.he@nswcc.org.au

Research summary

Dr Emily He is a consultant gastroenterologist and hepatologist in Sydney, and a senior research fellow at the University of Sydney. Her research interests include gastrointestinal cancer epidemiology, bowel cancer screening and prevention, as well as liver cancer control. Emily’s current work at Council NSW focuses on optimising bowel cancer screening and surveillance, and on analysing patterns and determinants of health service utilisation in liver cancer.


  • Doctor of Philosophy, Faculty of Medicine, University of NSW
  • Fellow of the Royal Australasian College of Physicians
  • Master of Public Health, University of NSW
  • Bachelor of Science (Medicine), Bachelor of Medicine and Bachelor of Surgery, University of NSW

Academic affiliations

Senior research fellow, the Sydney School of Public Health, The University of Sydney

Current student supervision

Emily currently co-coordinates the course “Diagnostic and Screening Tests”, offered to Masters students at the Sydney School of Public Health, The University of Sydney.

Emily is available to supervise Masters or PhD students enrolled at the University of Sydney.

Selected key publications

  • He E, Alison R, Blanks R, Pirie K, Reeves G, Ward RL, Steele R, Patnick J, Canfell K, Beral V, Green J. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: A large prospective study of women in england. International journal of epidemiology. 2019;48:549-558
  • He E, Lew JB, Egger S, Banks E, Ward RL, Beral V, Canfell K. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and up study cohort. Preventive medicine. 2018;106:185-193
  • He EY, Wyld L, Sloane MA, Canfell K, Ward RL. The molecular characteristics of colonic neoplasms in serrated polyposis: A systematic review and meta-analysis. The journal of pathology. Clinical research. 2016;2:127-137
  • Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to ifobt testing for colorectal cancer screening in australia. International journal of cancer. 2018;143:269-282
  • Lew JB, St John DJB, Xu XM, Greuter MJE, Caruana M, Cenin DR, He E, Saville M, Grogan P, Coupé VMH, Canfell K. Long-term evaluation of benefits, harms, and cost-effectiveness of the national bowel cancer screening program in australia: A modelling study. The Lancet. Public health. 2017;2:e331-e340